Cargando…
Correspondence to: “A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients.”
Autores principales: | Bansal, Pankaj, Sanghavi, Devang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559198/ https://www.ncbi.nlm.nih.gov/pubmed/34729156 http://dx.doi.org/10.1177/20406223211050495 |
Ejemplares similares
-
Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’
por: Guan, Jin-Tao, et al.
Publicado: (2021) -
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
por: Bo, Lulong, et al.
Publicado: (2011) -
A meta-analysis of granulocyte-macrophage colony-stimulating factor
(GM-CSF) antibody treatment for COVID-19 patients
por: Guan, Jin-Tao, et al.
Publicado: (2021) -
Efficacy and safety of granulocyte–macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis
por: Xi, An-ran, et al.
Publicado: (2022) -
The effect of granulocyte-macrophage colony stimulating factor (rGM-CSF) on macrophage function in microbial disease
por: Jones, Thomas C.
Publicado: (1996)